NeuroVive has established a subsidiary in Taiwan, NeuroVive Pharmaceutical Asia Inc. The company has established a Taiwanese subsidiary, NeuroVive Pharmaceutical Asia Inc. (NeuroVive Asia) as a step in this process. NeuroVive Asia has established a wholly-owned subsidiary, NeuroVive Pharmaceutical Asia Taiwan Inc. (NeuroViveTaiwan), in Taiwan to manage local operations. The subsidiary strengthens the group's presence in Asia and will be the driver behind existing project in the region, while conducting its own research and development operations under license from the parent company.

Michael L. Huang has been appointed CEO of NeuroVive's Asian group. Michael L. Huang is highly qualified for the assignment and has strong regional contacts.